sultosilic acid has been researched along with Hyperlipidemia, Familial Combined in 1 studies
*Hyperlipidemia, Familial Combined: A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franco, M; Masana, L; Oliván, JJ; Pérez-Jiménez, F; Pintó, X; Plana, N; Ros, E; Sust, M; Videla, S; Villoria, J | 1 |
1 trial(s) available for sultosilic acid and Hyperlipidemia, Familial Combined
| Article | Year |
|---|---|
Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
Topics: Adolescent; Adult; Aged; Benzenesulfonates; Cholesterol, LDL; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Pilot Projects; Pravastatin; Statistics, Nonparametric | 2004 |